MANF and early-onset autosomal dominant Alzheimer disease: MANF has also shown benefit in Parkinson's and Alzheimer's disease by protecting dopaminergic neurons and reducing intracellular α-synuclein aggregates in Parkinson's disease [77] and mitigating Aβ1-42-induced neuronal cell death in Alzheimer's disease [78].